A Randomized, Controlled, Open-label Study of Comparing Immunogenicity of Sequential Hepatitis B and Hepatitis A Vaccination vs Vaccination with a Dual Hepatitis B and Hepatitis A Vaccine among HIV-1 infected Subjects (HepVac)

Trial Profile

A Randomized, Controlled, Open-label Study of Comparing Immunogenicity of Sequential Hepatitis B and Hepatitis A Vaccination vs Vaccination with a Dual Hepatitis B and Hepatitis A Vaccine among HIV-1 infected Subjects (HepVac)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2014

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary) ; Hepatitis A vaccine inactivated; Hepatitis A-hepatitis B vaccine
  • Indications Hepatitis A; Hepatitis B
  • Focus Pharmacodynamics
  • Acronyms HepVac
  • Most Recent Events

    • 03 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top